Locations:
Adding 177Lu-PSMA-617 to ADT plus an ARPI cut the risk of radiographic progression or mortality by 28%
This single-port option offers advantages for appropriate patients
Expert recommendations introduce use of targeted agents
Large-scale database also reveals potential for immunotherapy to protect against cancer
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings may help guide discussions around prognosis and allogeneic stem cell transplantation
Study serves as ‘cautionary tale’ for physicians tempted to rely on liquid biopsy results alone
New guidelines empower clinicians with practical diagnostic framework
Phase 1 trial outcomes offer encouraging news for developing targeted therapy for solid tumors
Cleveland Clinic to administer first-of-its-kind T-cell therapy
Heavily pretreated patients experience improved progression-free survival and quality of life with CD20xCD3 therapy
Advertisement
Advertisement
Search